Latest Funding News

Plenti Group Limited reported a robust half-year performance for 1H26, with a 24% increase in its loan portfolio and a 147% surge in Cash Profit Before Tax, underscoring its growing market presence and operational efficiency.

Plenti Group Limited has reported a striking 147% increase in cash profit before tax for the first half of FY26, driven by record loan originations and robust credit performance. The fintech lender’s loan portfolio surged 24%, positioning it on track for a $3 billion milestone by March 2026.

Plenti Group Limited has reported a remarkable half-year performance for FY26, with revenues up 20% and profit soaring over tenfold to $10.5 million. The fintech lender’s loan portfolio expanded 24%, driven by strong demand across automotive, renewable energy, and personal loans.

Nexus Minerals reports robust one-metre assay results from Clement and Godfrey prospects, confirming significant gold mineralisation at Wallbrook. The Crusader-Templar Mine Development and Closure Plan has secured regulatory approval, paving the way for operational progress.

Podium Minerals has kicked off a comprehensive drilling campaign at its Parks Reef Platinum Group Metals Project, aiming to advance metallurgical testing and deepen resource insights. This move supports the company’s innovative Concentrator flowsheet development amid a tightening global PGM market.

K2 Asset Management Holdings Ltd marked a pivotal year with 17% revenue growth and a return to profitability, declaring a fully franked dividend and outlining ambitious growth plans across its core business pillars.

Magmatic Resources has launched a $3.5 million exploration drilling program at its Myall FJVA Project in partnership with Fortescue, targeting promising gold-copper porphyry deposits. The program includes both aircore and diamond drilling, alongside a geophysical survey, with initial results expected in early 2026.

Catapult Sports Ltd reported a 16.9% revenue increase to US$67.6 million for the half-year ended September 30, 2025, driven by strong subscription growth and key acquisitions. Despite a net loss of US$8.6 million, the company bolstered its cash position and expanded its product suite with AI and remote workflow innovations.

ALS Limited has posted a robust first half for FY26 with underlying EBIT growth of 14.7%, driven by strong performance in its Commodities segment and improved Life Sciences results. The company also raised its interim dividend and updated its growth outlook for the year.

ALS Limited reported a robust half-year performance with underlying revenue up 13.3% and net profit after tax rising 17.2%, driven by strong growth in both Commodities and Life Sciences divisions. The company also declared a higher interim dividend and advanced its global expansion strategy.

InFocus Group Holdings has extended its convertible note facility by $1 million, aiming to support growth in Thailand and new ventures in iGaming, pending shareholder approval.

Paradigm Biopharmaceuticals has drawn down US$5 million under its convertible note facility to fund the accelerated expansion of its global Phase 3 trial for knee osteoarthritis treatment.